First Time Loading...
S

StemRIM Inc
TSE:4599

Watchlist Manager
StemRIM Inc
TSE:4599
Watchlist
Price: 475 JPY 0.42% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
StemRIM Inc

Wall Street analysts forecast StemRIM Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for StemRIM Inc is 918 JPY with a low forecast of 909 JPY and a high forecast of 945 JPY.

Lowest Forecast
Wall Street Target
909 JPY
91% Upside
Average Forecast
Wall Street Target
918 JPY
93% Upside
Highest Forecast
Wall Street Target
945 JPY
99% Upside
Lowest
Price Target
909 JPY
91% Upside
Average
Price Target
918 JPY
93% Upside
Highest
Price Target
945 JPY
99% Upside
StemRIM Inc Competitors:
Price Targets
C
049960
Cell Biotech Co Ltd
364% Upside
M
086900
Medy Tox Inc
73% Upside
S
688293
Shanghai OPM Biosciences Co Ltd
39% Upside
9995
RemeGen Co Ltd
46% Upside
C
049960
Cell Biotech Co Ltd
364% Upside
M
086900
Medy Tox Inc
73% Upside
S
688293
Shanghai OPM Biosciences Co Ltd
39% Upside
9995
RemeGen Co Ltd
46% Upside
300439
MedicalSystem Biotechnology Co Ltd
136% Upside
302440
SK Bioscience Co Ltd
4% Downside
688687
Beijing Kawin Technology Share-holding Co Ltd
33% Upside
6160
Beigene Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
StemRIM Inc

For the last 5 years the compound annual growth rate for StemRIM Inc's revenue is 64%. The projected CAGR for the next 3 years is -39%.

64%
Past Growth
-39%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
StemRIM Inc

Operating Income forecast
is not available for
StemRIM Inc

Net Income
Forecast

Net Income Estimate
StemRIM Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is StemRIM Inc's stock price target?
Price Target
918 JPY

According to Wall Street analysts, the average 1-year price target for StemRIM Inc is 918 JPY with a low forecast of 909 JPY and a high forecast of 945 JPY.

What is StemRIM Inc's Revenue forecast?
Projected CAGR
-39%

For the last 5 years the compound annual growth rate for StemRIM Inc's revenue is 64%. The projected CAGR for the next 3 years is -39%.

ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.